Category: Pharmaceuticals
St. Louis based Washington University’s researchers have reportedly established a new technique to overcome the blood-brain barrier (BBB), in a bid to administer medications to the brain. Sources familiar with the development claim that these medications would particularly heal brain tumors classified under the difficult-to-treat …
One of the largest pharmaceutical companies in the world, Merck & Co has reportedly gained approval for its cancer drug Keytruda to be officially used in the European countries. According to sources familiar with the development, the drug will be used in association with chemotherapy …
Roche, a Swiss multinational healthcare company, has reportedly made it to the headlines with regards to its drug pricing issue in Britain. According to sources familiar with the matter, NICE (National Inst. for Health & Care Excellence) has disapproved its drug ‘Ocrevus’ on the grounds …
India’s leading pharmaceutical company, Glenmark Pharmaceuticals Ltd, has reportedly announced that its subsidiary has acquired the marketing authorization in Germany for Fluticasone / Salmeterol DPI (Dry Powder Inhaler). If sources are to be relied on, the product is a generic version of GlaxoSmithKline plc’s (GSK) …
Intermountain Healthcare, headquartered in Salt Lake City, Utah, has officially announced the launch of Civica Rx, a non-profit, hospital-led generic drug company. Aimed at preventing drug shortages and cutting costs, Intermountain Health is supposedly partnering with three philanthropic groups and six other hospital systems to …
Aurobindo Pharma, the second-biggest drugmaker in India, recently announced that it has agreed to buy Sandoz’s dermatology business and a portfolio of its oral solid products in U.S., as well as manufacturing and commercial infrastructure for a total of $900 million. As part of the …
Pfizer recently made an announcement confirming that its experimental oral inhibitor, Janus kinase 3 (JAK3) or PF-06651600, has been granted the Breakthrough Therapy designation by the U.S. Food and Drug Administration (FDA). Apparently, the inhibitor is being developed for treating patients suffering from alopecia areata, …
The National Health Service (NHS), the national healthcare system of England, has reportedly made plans to treat young people and children stricken with cancer with a costly yet revolutionary cancer drug, which has enormous potential to transform the way this disease is treated. According to …
Renowned New York-based pharma magnate Pfizer Inc., has reportedly axed two trials of its Domagrozuma antibody. As per sources, the candidate development has been halted on the grounds of its disappointing failure to meet the required efficacy targets. For the uninitiated, the anti-myostatin antibody is …
